Documents › 3a0160e9792366039c4c24908c2d7e1cb47c0353:1-73

NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users

POST board policyreference 2022-12 73 pages (file pages 1–73) original file
About this document
Layer
attachment: a document a meeting packet links to
Type as titled
publication (kind from doc_type)
File
3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
Cases
POST 2313715 · Jaime Bermudez (filed under case)

About: Jaime Bermudez (case)

Page 50 · file page 50 larger image
Image of page 50; its text is alongside
Text: OCR

Discussion

This study was the largest research effort to date in the United States to conduct independent toxicological analyses of blood specimens from roadway users who were seriously or fatally injured in motor vehicle crashes. The study extended beyond drivers to include pedestrians, bicyclists, passengers, and others (e.g., moped, ATV, and electric kick scooter riders) who were injured or killed in crashes with motor vehicles on roadways.

The report focused on drivers because of the large sample size available and the known potentially impairing effects of the studied drugs on motor vehicle operators. The overall drug positivity rate (including alcohol) of 54.4% for trauma center driver cases in this study is very similar to an ongoing study being conducted at emergency departments in Canada where 50.8% of drivers tested positive for one or more drugs through May 2021 when using a similar drug panel and data collection approach (Brubacher et al., 2021). While direct comparisons across these studies should be made with caution, the current study's trauma center driver cannabinoid (25.0%) and alcohol (21.6%) raw prevalence rates are higher than those reported in the Canadian study (18.8% and 15.5% respectively). The Canadian study reported higher positivity rates for opioids (11.0%) than the current study which found 8.6% opioid positivity for trauma center driver cases. Comparisons of the other drug categories across the two studies are limited because of the combinations of individual drugs that were included in the categories such as sedatives. Other factors limiting comparisons across the studies include toxicological testing methods and cutoffs utilized to define drug positivity. Regardless of their approach differences, the combined findings from these two studies suggest that seriously injured drivers in the United States and Canada are more likely than not to have alcohol or another potentially impairing drug in their system when the crash occurred.

The current study's findings do offer some suggestion that drug prevalence could be higher in the crashes where a driver is killed. Notably, 68.8% of the ME driver cases in this study's sample had one or more drugs on the study's toxicology panel detected in the driver's system. Of the total ME driver sample, 33.9% had two or more drug categories in their systems. While direct comparisons of the ME and trauma center driver case results should be made with caution, the differences in individual drug and two or more drug category prevalence rates observed offer some suggestion that certain drugs, or combinations of drugs, could potentially be associated with more severe crashes resulting in driver death.

This study also examined associations of drug positivity with driver age, sex, time of crash, and day of crash (weekday versus weekend). The findings suggest that within this sample of drivers, drug positivity rates had reliable associations with each of these factors. Males and females showed differences in positivity, with males more likely to be positive for some categories of drugs (i.e., alcohol, cannabinoids, stimulants) and females more likely to be positive for others (i.e., sedatives, antidepressants, OTC drugs). There were also a variety of differences in drug category positivity by age group that are potentially useful for informing targeted countermeasures depending on the intended audience.

The observed differences by time of day (increased overall drug positivity at night) and day of week (increased drug positivity on the weekend) are not surprising given similar results observed in past NHTSA roadside and crash risk studies referenced in the introduction of this report. Of interest, however, is that cannabinoids (active THC) positivity was still relatively high (over 20%) during the day and on weekdays, and sedative and opioid prevalence were actually higher

42

Keys: ← → or j k turn pages; / finds.